Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
As of today, Moderna(MRNA) shares are valued at $201.27. The company's market cap stands at 79.87B, with a P/E ratio of -25.06.
As of 2026-10-23, Moderna(MRNA) stock has fluctuated between $183.00 and $206.97. The current price stands at $201.27, placing the stock +10.0% above today's low and -2.8% off the high.
The Moderna(MRNA)'s current trading volume is 21.57M, compared to an average daily volume of 20.48M.
During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $254.48 at its peak.
During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $254.48 at its peak.
MRNA News
Moderna and other pharmaceutical companies are under great pressure to produce successful new drugs. Adam Glanzman / Bloomberg News To the scientific world, Mo...
Biotech company Moderna (MRNA) saw its shares fall by as much as 25% on Thursday, October 22, despite positive results from a late-stage trial of its personaliz...
Moderna and Merck proved their custom cancer vaccine cut the risk of melanoma returning for longer than the cancer drug Keytruda, but it may take several years...
Analyst ratings
52%
of 27 ratingsMore MRNA News
Moderna (MRNA) announced an update on their ongoing clinical study. ModernaTX, Inc. is advancing a new study called “A Phase 1/2, Randomized, Placebo-Controlle...
...
Moderna (MRNA) closed Thursday down ~17% after phase 3 data was leaked on the company's personalized cancer vaccine, intismeran autogene, and the Street is offe...
You may know the name Moderna (MRNA -5.69%) very well thanks to the company's blockbuster coronavirus vaccine. That was the biotech's first commercialized produ...
Investing Moderna Sinks 4% After 18% Plunge as Melanoma Vaccine Selloff Extends; Merck and Pfizer Slip Full late-stage results for the personalized melanoma vac...
Citi analyst Geoff Meacham says Moderna (MRNA) shares dropped yesterday after leaked, then later confirmed, Phase 3 INTerpath-001 data demonstrated intismeran p...
Moderna (MRNA) and BioNTech (BNTX) are biotech stocks focused on cancer vaccines as they enter their next growth phase. According to TipRanks Comparison Stock t...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.